Also known as: Romazicon / Anexate (brand)
Flumazenil is a competitive benzodiazepine receptor antagonist used for the reversal of benzodiazepine-induced sedation and to manage benzodiazepine overdose. It acts at GABA-A receptors, rapidly reversing CNS depression caused by benzodiazepine agents.
Mediocon Inc manufactures Flumazenil IP/BP/USP with high purity suitable for parenteral and injectable pharmaceutical formulations across critical care settings. Every batch undergoes rigorous quality testing ensuring full compliance with pharmacopoeial standards.
Key Features
Applications
Why Choose Mediocon
| Parameter | Specification |
|---|---|
| Assay | NLT 98.0% & NMT 102.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 10 ppm |
| Residual Solvents | Complies ICH Q3C |
| Microbial Limits | Complies |
| Identification | HPLC & IR Compliant |
| pH (1% solution) | 4.5 – 6.5 |
| Packing | 25 kg HDPE drums / as per requirement |